跳至主要内容
临床试验/IRCT20190912044757N1
IRCT20190912044757N1已完成3 期

Investigation of the Effect of magnesium oxid supplementation on gene expression levels associated with insulin, lipid and inflammatory metabolism in diabetic hemodialysis patients

Islamic Azad University0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
45 years 至 75 years(—)
性别
All

入选标准

  • ?Diabetic Hemodialysis patients with glomerular filtration less than 10 or less than 25 ml / min with malnutrition or hyperkalemia
  • Age 45-75 years
  • Moderate hypertension (systolic blood pressure between 160-140 mmHg and diastolic blood pressure between 90-100 mmHg)

排除标准

  • Unwillingness to participate in the study
  • Hypothyroidism or hyperthyroidism (clinical evaluation by a specialist physician and laboratory test)
  • Specific illness that may lead to hospitalization
  • High blood pressure (systolic pressure above 160 and diastolic pressure above 100 mm Hg)

研究者

相似试验